Piramal Pharma releases Sustainability Report FY 2023-24
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
Emcure will play a crucial role in ensuring the availability of high-quality, low-cost versions of lenacapavir in 120 countries
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
The transaction involves the acquisition of 100% shareholding of Bharat Serums and Vaccines (BSV) by Mankind Pharma
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
The observations are of procedural in nature and will be responded to within the stipulated time
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The inspection concluded with the issuance of a form 483 with five observations
Subscribe To Our Newsletter & Stay Updated